An efficient and safe MUC1-dendritic cell-derived exosome conjugate vaccine elicits potent cellular and humoral immunity and tumor inhibition in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An efficient and safe MUC1-dendritic cell-derived exosome conjugate vaccine elicits potent cellular and humoral immunity and tumor inhibition in vivo

Published:2022-01 Issue: Volume:138 Page:491-504
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Zhu Haomiao,Wang Kun,Wang Zhaoyu,Wang Danyang,Yin Xiaona,Liu Yonghui,Yu Fan,Zhao Wei

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference72 articles.

1. Cancer immunotherapy: a treatment for the masses;Blattman;Science,2004

2. Generation of a graft versus anticancer immune response through skin allograft with tumor;Fang;J. Biomed. Nanotechnol.,2018

3. One-shot immunomodulatory nanodiamond agents for cancer immunotherapy;Zhang;Adv. Mater.,2016

4. Synthetic multivalent glycopeptide-lipopeptide antitumor vaccines: impact of the cluster effect on the killing of tumor cells;Cai;Angew. Chem. Int. Ed. Engl.,2014

5. Covalent bond or noncovalent bond: a supramolecular strategy for the construction of chemically synthesized vaccines;Gao;Chemistry,2014

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in exosomes utilization for clinical applications in cancer;Trends in Cancer;2024-08

2. Exosome-based anticancer vaccines: From Bench to bedside;Cancer Letters;2024-07

3. Different origin-derived exosomes and their clinical advantages in cancer therapy;Frontiers in Immunology;2024-06-27

4. Propelling Minimally Invasive Tissue Regeneration With Next‐Era Injectable Pre‐Formed Scaffolds;Advanced Materials;2024-06-20

5. Engineered dendritic cells-derived exosomes harboring HIV-1 Nefmut-Tat fusion protein and heat shock protein 70: A promising HIV-1 safe vaccine candidate;International Journal of Biological Macromolecules;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3